Body composition as predictor of toxicity and outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (Nivo).

被引：0
|
作者：
Shachar, Shlomit Strulov
Fried, Rachel
Shafran, Itamar
Moskovitz, Mor Tal
Williams, Grant Richard
Bar-Sela, Gil
Reiner-Benaim, Anat Strulov
Wollner, Mira
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Rambam Hlth Care Campus, Harduf, Israel
[5] Rambam Hlth Care Campus, Div Oncol, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of baseline body mass index (BMI) with overall survival (OS) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) treated with nivolumab (N) and pembrolizumab (P)
    Zhi, Jizu
    Khozin, Sean
    Kuk, Deborah
    Torres, Aracelis Z.
    Sorg, Rachael
    Lee, Shannon E.
    Miksad, Rebecca A.
    Pazdur, Richard
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Alterations in body composition in Indian patients with non-small cell lung cancer
    Mohan, Anant
    Poulose, Rosemary
    Ansari, Ashraf
    Madan, Koran
    Hadda, Vijay
    Khilnani, G. C.
    Guleria, Randeep
    LUNG INDIA, 2019, 36 (04) : 295 - 298
  • [33] The association between body composition, quality of life (QoL), overall survival (OS) and decision to treat (DTT) in patients with metastatic non-small cell lung cancer (mNSCLC)
    Lee, Hyejung
    Haaland, Ben
    Akerley, Wallace L.
    Coletta, Adriana M.
    Yap, Jeffrey T.
    Puri, Sonam
    Kerrigan, Kathleen Claire
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 377 - 377
  • [34] Gene expression (GE)-based biomarkers associated with nivolumab response in a real-life cohort of patients with metastatic non-small cell lung cancer (mNSCLC)
    Radosevic-Robin, N.
    Ong, S.
    Warren, S. E.
    Kossai, M.
    Godfraind, C.
    Masson, M.
    Janicot, H.
    Merle, P.
    Dubray-Longueras, P.
    Durando, X.
    Morel, P.
    Cesano, A.
    Penault-Llorca, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Phase I Trial of The Combined Treatment of Nivolumab and Stereotactic Body Radiotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
    Onishi, H.
    Marino, K.
    Kuriyama, K.
    Komiyama, T.
    Maehata, Y.
    Aoki, S.
    Araya, M.
    Saito, R.
    Matsuda, M.
    Akita, T.
    Yamada, T.
    Saito, M.
    Sano, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E92 - E92
  • [36] Survival outcomes with the use of immunotherapy (IO) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) at a large hybrid cancer institute.
    Young, Joanna Alyse
    Clarkson, Christina
    He, Jiaxian
    Slaughter, Daniel
    Haggstrom, Daniel Ernest
    Carrizosa, Daniel R.
    Mileham, Kathryn Finch
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Predictive and prognostic value of systemic inflammatory response biomarkers in patients receiving nivolumab for metastatic non-small cell lung cancer (NSCLC).
    Gervais, Claire
    Boudou-Rouquette, Pascaline
    Jouinot, Anne
    Huillard, Olivier
    Alexandre, Jerome
    Arrondeau, Jennifer
    Giraud, Frederique
    Chapron, Jeanne
    Alifano, Marco
    Revel, Marie-Pierre
    Dusser, Daniel
    Damotte, Diane
    Mansuet-Lupo, Audrey
    Goldwasser, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] An evaluation of toxicity and outcomes in West of Scotland patients receiving second line treatment of non-small cell lung cancer
    Laskey, J.
    MacLean, F.
    LUNG CANCER, 2014, 83 : S5 - S6
  • [39] Outcomes of nivolumab (NIVO)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC) in United States community oncology practice.
    Nadler, Eric
    Espirito, Janet
    Wilson, Thomas
    Gupte-Singh, Komal
    Rao, Sumati
    Korytowsky, Beata
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [40] PATIENT CHARACTERISTICS AND FIRST LINE TREATMENTS AMONG MEDICARE PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC)
    Ejzykowicz, F.
    Chen, X.
    Petrilla, A.
    Schroeder, A.
    Dietz, K.
    Agatep, B.
    Burke, T.
    Lopes, G.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
12345